Search: (WFRF:(Jerkeman Mats)) pers:(de Nully Brown Peter)
> (2022) >
Idelalisib in relap...
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
-
- Fjordén, Karin (author)
- Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lymfom - Klinisk forskning,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lymphoma - Clinical Research,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Sweden
-
- Ekberg, Sara (author)
- Karolinska Institutet,Karolinska Institute,Karolinska Inst, Sweden
-
- Kuric, Nevzeta (author)
- Halmstad Cty Hosp, Sweden,Halmstad County Hospital
-
show more...
-
- Smedby, Karin E. (author)
- Karolinska Institutet
-
- Lagerlöf, Ingemar (author)
- Linköping University,Linköpings universitet,Institutionen för hälsa, medicin och vård,Medicinska fakulteten
-
- Larsen, Thomas S. (author)
- Odense Univ Hosp, Denmark,Odense University Hospital
-
- Jorgensen, Judit M. (author)
- Aarhus Univ Hosp, Denmark,Aarhus University Hospital
-
- de Nully Brown, Peter (author)
- Copenhagen Univ Hosp, Denmark,Copenhagen University Hospital
-
- Jerkeman, Mats (author)
- Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lymfom - Klinisk forskning,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Onkologi övergripande,Institutionen för kliniska vetenskaper, Lund,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lymphoma - Clinical Research,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Oncology corporate,Department of Clinical Sciences, Lund,Lund Univ, Sweden
-
show less...
-
(creator_code:org_t)
- 2021-08-25
- 2022
- English.
-
In: British Journal of Haematology. - : WILEY. - 0007-1048 .- 1365-2141. ; 196:2, s. 437-440
- Related links:
-
https://onlinelibrar...
-
show more...
-
http://dx.doi.org/10... (free)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
show less...
Subject headings
Close
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Idelalisib; relapsed; refractory DLBCL; transformed lymphoma
Publication and Content Type
- vet (subject category)
- art (subject category)
Find in a library
To the university's database